ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
4.090
-0.020 (-0.49%)
At close: Apr 22, 2026, 4:00 PM EDT
4.090
0.00 (0.00%)
After-hours: Apr 22, 2026, 7:00 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $520.21 million as of April 22, 2026. Its market cap has increased by 344.93% in one year.
Market Cap
520.21M
Enterprise Value
700.96M
1-Year Change
344.93%
Ranking
Category
Stock Price
$4.09
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $520.21M, a decrease of -74.53%. That is a compound annual growth rate of -20.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 522.75M | 19.54% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verastem | 572.74M |
| enGene Therapeutics | 571.42M |
| Upstream Bio | 543.66M |
| Tectonic Therapeutic | 540.02M |
| Valneva SE | 535.43M |
| Immix Biopharma | 534.89M |
| Candel Therapeutics | 528.84M |
| Fulcrum Therapeutics | 528.81M |